1. Home /
    2. Altai Protocol Library /
  2. New Protocol: subQ daratumumab + CyBorD in light chain amyloidosis

Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Kütüphanede Ara Ara
Altai Protocol Library

New Protocol: subQ daratumumab + CyBorD in light chain amyloidosis

  •  
New Protocol: subQ daratumumab + CyBorD in light chain amyloidosis
Study:
  • Open-label, randomized phase III trial (ANDROMEDA)
  • Newly diagnosed light chain amyloidosis with >=1 affected organ
  • CyBorD with or without subQ daratumumab (n= 195 and 193, respectively)
Efficacy:
  • Hematologic CR: 42% vs. 13% (p<0.0001)
  • HR for Organ deterioration PFS: 0/58 [0.37-0.92]

Not published as of Feb 6, 2021. Based on package insert

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761145s002lbl.pdf

Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More